ZA821621B - Dihydrobenzofuran derivatives,a process for their preparation and their use - Google Patents

Dihydrobenzofuran derivatives,a process for their preparation and their use

Info

Publication number
ZA821621B
ZA821621B ZA821621A ZA821621A ZA821621B ZA 821621 B ZA821621 B ZA 821621B ZA 821621 A ZA821621 A ZA 821621A ZA 821621 A ZA821621 A ZA 821621A ZA 821621 B ZA821621 B ZA 821621B
Authority
ZA
South Africa
Prior art keywords
preparation
dihydrobenzofuran derivatives
dihydrobenzofuran
derivatives
Prior art date
Application number
ZA821621A
Other languages
English (en)
Inventor
Roger Edward Markwell
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA821621B publication Critical patent/ZA821621B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA821621A 1981-03-12 1982-03-11 Dihydrobenzofuran derivatives,a process for their preparation and their use ZA821621B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8107837 1981-03-12

Publications (1)

Publication Number Publication Date
ZA821621B true ZA821621B (en) 1983-01-26

Family

ID=44720366

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA821621A ZA821621B (en) 1981-03-12 1982-03-11 Dihydrobenzofuran derivatives,a process for their preparation and their use

Country Status (10)

Country Link
US (1) US4428940A (xx)
EP (1) EP0060668B1 (xx)
JP (1) JPS57159781A (xx)
AU (1) AU556040B2 (xx)
CA (1) CA1183836A (xx)
DE (1) DE3266746D1 (xx)
ES (1) ES510401A0 (xx)
IE (1) IE52631B1 (xx)
NZ (1) NZ199967A (xx)
ZA (1) ZA821621B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387717B (de) * 1983-03-16 1989-03-10 Immuno Ag Verfahren zum bestimmen von unvertraeglichkeitsreaktionen verursachenden substanzen in therapeutisch und prophylaktisch anzuwendenden blutprodukten sowie verwendung des verfahrens
US4801721A (en) * 1984-08-16 1989-01-31 Ryan James W Stereospecific synthesis of carboxyalkyl peptides
AU2002348276A1 (en) 2001-11-16 2003-06-10 Bristol-Myers Squibb Company Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
US7459474B2 (en) 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8080579B2 (en) 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US8198311B2 (en) 2006-11-01 2012-06-12 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
EP2089355A2 (en) 2006-11-01 2009-08-19 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2015027021A1 (en) 2013-08-22 2015-02-26 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192878A (en) 1976-12-03 1980-03-11 E. R. Squibb & Sons, Inc. Derivatives of thiazolidinecarboxylic acids and related acids
IT7851510A0 (it) * 1977-10-28 1978-10-16 Sandoz Ag Ammidi di amminoacidi ciclici loro preparazione e loro applicazione quali medicamenti
US4282235A (en) 1978-05-22 1981-08-04 E. R. Squibb & Sons, Inc. Derivatives of thiazolidinecarboxylic acids and related acids
US4308392A (en) 1979-12-03 1981-12-29 E. R. Squibb & Sons, Inc. Hydroxamic acid derivatives of mercaptoacyl amino acids
GB2065643B (en) 1979-12-13 1983-08-24 Kanegafuchi Chemical Ind Optically active n-mercaptoalkanoylamino acids

Also Published As

Publication number Publication date
EP0060668A1 (en) 1982-09-22
IE52631B1 (en) 1988-01-06
IE820556L (en) 1982-09-10
ES8303402A1 (es) 1983-02-01
CA1183836A (en) 1985-03-12
AU8135182A (en) 1982-09-16
JPS57159781A (en) 1982-10-01
US4428940A (en) 1984-01-31
NZ199967A (en) 1985-08-30
EP0060668B1 (en) 1985-10-09
AU556040B2 (en) 1986-10-23
ES510401A0 (es) 1983-02-01
DE3266746D1 (en) 1985-11-14

Similar Documents

Publication Publication Date Title
DE3270360D1 (en) Cephalosporin derivatives, and process for their preparation
DE3167097D1 (en) Acylphosphinesulfide compounds, process for their preparation and their use
ZA821621B (en) Dihydrobenzofuran derivatives,a process for their preparation and their use
GB2108999B (en) Cyclopentadiene derivatives, method for preparing, and use thereof
DE3261973D1 (en) Process for preparing 1,1-dihalo-1,2,2,2,-tetrafluoroethanes
DE3263276D1 (en) Oximinophosphoric-acid derivatives, process for their preparation and their use as pesticides
EG15752A (en) Substituted azolyl-phenoxy derivatives,process for their preparation,and their use as fungicides
EP0098620A3 (en) Alpha,beta-dihydropolyprenyl derivatives and a process for preparing these derivatives
DE3160780D1 (en) 2,3-dichloro-2-trifluoromethyl-1,1,1,3,4,4,5,5,5-nonafluoropentane and process for its preparation
DE3268290D1 (en) Addition compounds, process for their production and their use
RO87709B (ro) Procedeu pentru prepararea unor 1,1-alcandiol-carboxilati
IL65387A0 (en) 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives and a process for the preparation thereof
DE3264284D1 (en) Bisimidazolines, process for their preparation and their use
BG38940A3 (en) Method for preparing penicillanoyloxymethyl penicillanate- 1, 1- dioxide
GR65242B (en) Method for the preparation of 2-n-acyl and alkyl-6'-n-alkyl-and 6',6'-di-n-alkyl derivatives of fortimicin a and b
ZA828238B (en) 1-(3,4,5-trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted pirerazine derivatives and a process for preparation thereof
DE3169609D1 (en) Process for preparing m,m'-dinitrobenzophenone
DE3264631D1 (en) 4-halogenostilbene derivatives and process for their preparation
ZA823950B (en) 4-amino-benzylamine derivatives,a process for their preparation and their use as pharmaceuticals
ZA827368B (en) Substituted 6-phenoxypyrid-2-ylmethyl-vinylcyclopropanecarboxylates,a process for their preparation,and their use as pest-combating agents
ZA825239B (en) Oxothienobenzoxepins,a method for their preparation and their use as medicaments
GR65214B (en) Method for the preparation of 6'-n-alkyl-and 6',6'-di-n-alkyl derivatives of fortimicins a and b
DE3278931D1 (en) 1,1-diphenylalkenes and a process for their preparation
IL67581A (en) Aminopropylaminobleomycin derivatives and process for preparation thereof
DE3267376D1 (en) Quinidines, process for their preparation and their pharmaceutical application